Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alexandria Real Estate Equities Inc (ARE) vs Heron Therapeutics Inc (HRTX) Price & Performance

Alexandria Real Estate Equities IncTrade
Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Alexandria Real Estate Equities Inc vs Heron Therapeutics Inc — how do they compare? Alexandria Real Estate Equities Inc trades at $48.5 (market cap $8.28B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Alexandria Real Estate Equities Inc is far larger — about 134.7× Heron Therapeutics Inc's market cap, and Alexandria Real Estate Equities Inc pays a 5.99% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

AREHRTX
Market Cap
$8.28B$61.47M
Sector
Real EstateHealth
52-Week High
$87.45$1.49
52-Week Low
$40.41$0.32
Enterprise Value
$20.98B$168.21M
Dividend Yield
5.99%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alexandria Real Estate Equities Inc

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.

Read more on ARE

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX